Patents
Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
05/2000
05/04/2000WO2000024753A1 Chromogenic substrates of sialidase and methods of making and using the same
05/04/2000WO2000024728A1 Microbial transformation product
05/04/2000WO2000024405A1 Compounds and their therapeutic use with diabetic complications
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/04/2000DE19850572A1 Preparation of new or known luteolin compounds by reducing flavonoids with sodium dithionite, used e.g. as nutritional supplements, cosmetic UV filters or cardiovascular drugs
05/04/2000DE19850570A1 Production of new or known tri-O-hydroxyalkyl quercetin or isoquercetin derivatives, e.g. useful as food supplements, comprises enzymatic hydrolysis of tri-O-hydroxyalkyl rutin derivatives in an aqueous medium
05/04/2000DE19850282A1 Preparation of new or known tris-hydroxyalkyl quercetin and isoquercetin derivatives by enzymatic cleavage of rutin derivatives, used e.g. as nutritional supplements, cosmetic UV filters or cardiovascular drugs
05/04/2000CA2348844A1 Compounds and their therapeutic use with diabetic complications
05/04/2000CA2347803A1 Microbial transformation product
05/04/2000CA2311387A1 Chromogenic substrates of sialidase and methods of making and using the same
05/03/2000EP0997472A2 Spirocyclic C-glycosides
05/03/2000EP0997471A2 Process for the preparation of glycosides
05/03/2000EP0996455A1 $g(a)-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF
05/03/2000EP0996451A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity
04/2000
04/27/2000WO2000023453A1 Crystallization of doxorubicin hydrochloride
04/27/2000WO2000023406A1 Processing of contaminated fatty alcohol mixtures
04/27/2000DE19848548A1 Purification of fatty alcohol mixture, especially before recycling in alkyl oligoglycoside manufacture, involves treatment with acid and distillation from residue
04/27/2000CA2346325A1 Bioflavonoids as plasma high density lipoprotein level increasing agent
04/26/2000EP0994888A1 Process for the acylation of amino alcohols
04/26/2000EP0994887A2 Modified glycosides, compositions comprised thereof and methods of use thereof
04/26/2000EP0994853A2 Compounds and methods for the inhibition of the expression of vcam-1
04/26/2000EP0771209A4 Novel peptides
04/26/2000CN1251521A Compound and method for therapeutic intervention in preventing diabetic complications
04/25/2000US6054478 Antifungal sordaridin derivatives
04/25/2000CA2110386C Method for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
04/20/2000WO1999066063A3 Nucleosidic and non-nucleosidic folate conjugates
04/20/2000DE19845405A1 Arylsubstituierte Propanolaminderivate und deren Verwendung Aryl-substituted Propanolaminderivate and their use
04/19/2000EP0666268B1 Novel sphingoglycolipid and use thereof
04/19/2000CN1051559C Novel aminooligosaccharide derivative and process for preparing same
04/19/2000CN1051558C Anthracyclie derivatives, prepn. method and use thereof
04/13/2000WO2000020428A2 Synthesis of oligosaccharides, reagents and methods related thereto
04/13/2000WO2000020392A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use
04/13/2000CA2346237A1 Synthesis of oligosaccharides, reagents and methods related thereto
04/12/2000EP0992508A1 Compositions comprising alkylpolyglycosides and fatty alcohols and uses thereof
04/11/2000US6048842 Antidiabetic agent
04/11/2000US6048707 Analyzing structural relationship between monosaccharides of carbohydrate; derivatizing carbohydrate, converting to monosaccharides, forming labeled monosaccharides, separating monosaccharides by electrophoresis, detecting monosaccarides
04/11/2000CA1340952C Chemiluminescent 1,2-dioxetane compounds
04/06/2000WO2000018779A1 Tenside mixtures
04/06/2000WO2000018410A1 Glutaraldehyde modified chemotherapeutic agents and methods of use thereof
04/06/2000WO1999061583A3 Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
04/05/2000EP0990661A1 Proactive antitumor compounds
04/05/2000EP0990439A1 Bisaryl compounds and cancer remedies containing the same
04/05/2000EP0989989A1 13-dihydro-3'aziridino anthracyclines
04/05/2000EP0989857A1 Novel therapeutic agents that modulate enzymatic processes
04/05/2000CN1249758A Purification of polyol polyesters using mixing vessel with control of mixing
04/05/2000CN1249757A Reduced calorie cooking and frying oils having improved stability against hydrolysis, and preparation thereof
04/05/2000CN1249308A Compound extracted from heroubill herb and its medicinal preparation
04/05/2000CN1051090C Ganglioside GM3 analog having sialic acid residue fluorinated at 9-position
03/2000
03/30/2000WO2000017216A1 Carboxymethylgalactose derivatives
03/30/2000WO2000017195A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/30/2000DE19844004A1 Tensidmischungen Surfactant mixtures
03/30/2000CA2344390A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/30/2000CA2278960A1 Spirocyclic c-glycosides
03/29/2000EP0988860A1 NKT CELL ACTIVATORS CONTAINING $g(a)-GLYCOSYLCERAMIDES
03/29/2000EP0988060A2 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy
03/29/2000CN1248976A Protected aminosugars
03/28/2000US6043367 Anticarcinogenic agent
03/28/2000US6043242 Imidazopyridazines
03/28/2000CA2164152C New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
03/28/2000CA2014472C N-acyl derivatives of the ll-e33288 antitumor antibiotics
03/23/2000WO2000015174A2 Bioflavonoid as blood glucose level lowering agent
03/23/2000WO2000015047A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases
03/23/2000CA2344322A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases
03/23/2000CA2342608A1 Bioflavonoid as blood glucose level lowering agent
03/22/2000EP0987265A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/22/2000EP0986568A1 Novel class of nucleic acid cationic transfecting agents
03/22/2000EP0986384A1 Inhibitors of protein isoprenyl transferases
03/21/2000US6040433 Monomers suitable for use in sulfoxide-mediated reactions to provide good chemical and stereochemical yields of carbohydrates
03/16/2000WO2000014097A2 Novel pyranoses
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/16/2000CA2342855A1 Novel pyranoses
03/15/2000EP0667351B1 Compound uch9
03/15/2000EP0648279B1 Acceptor for fucosyltransferase
03/15/2000EP0635063B1 Process for the preparation of glycolipids
03/15/2000CN1247564A Method for activating human antigen presenting cells, activated human antigen presenting cells, and use of same
03/14/2000US6037467 Methods for preparing carbohydrate-containing hydrophilic polymers
03/14/2000US6037460 For surfactants, detergents or emulsifers especially cosmetic cleansing agents
03/08/2000EP0984018A1 Derivatives of antifungal substance be-31405 and process for producing the same
03/08/2000EP0983374A1 Process for the production of isomaltulose and other products
03/08/2000EP0983286A1 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
03/07/2000US6034122 Combined use of diclofenac and tribenoside to treat osteoarthritis
03/07/2000US6034055 Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars
03/07/2000US6033669 Methods for generating cytotoxic T cells and treatment of diseases thereby
03/02/2000WO2000011013A1 Modified nucleomonomers and methods of use thereof
03/02/2000WO1999064409A3 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000WO1998051662A3 Compounds and methods for the inhibition of the expression of vcam-1
03/01/2000EP0981542A1 20(s) camptothecin glycoconjugates
03/01/2000EP0981533A1 A process for the crystallization of lactitol
03/01/2000EP0981343A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
03/01/2000CN1246124A 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
03/01/2000CN1246122A Purification of polyol fatty acid polyesters using mixing vessel with controlled mixing
03/01/2000CN1246120A Imidazopyridazines compound
02/2000
02/29/2000US6030997 Acid labile prodrugs
02/29/2000US6030996 Mur D inhibiting compounds, compositions containing such compounds and methods of use
02/29/2000US6030815 Enzymatic synthesis of oligosaccharides
02/29/2000CA2003662C Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof